In Vivo Brain Dialysis Study of the Somatodendritic Release of Serotonin in the Raphe Nuclei of the Rat: Effects of 8‐Hydroxy‐2‐(Di‐n‐Propylamino)tetralin
暂无分享,去创建一个
F. Artigas | A. Adell | F Artigas | A. Carceller | A Adell | A Carceller
[1] G. Damsma,et al. Characterization of dopamine release in the substantia nigra by in vivo microdialysis in freely moving rats , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[2] J. Bockaert,et al. Two distinct mechanisms, differentially affected by excitatory amino acids, trigger GABA release from fetal mouse striatal neurons in primary culture , 1989, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[3] H. Schoemaker,et al. [3H]8-OH-DPAT labels the serotonin transporter in the rat striatum. , 1986, European journal of pharmacology.
[4] W. Wolf,et al. The 5-HT transporter is an additional site of action for the 5-HT agonists RU 24969 and TFMPP , 1991, Neurochemistry International.
[5] E. Azmitia. The Serotonin-Producing Neurons of the Midbrain Median and Dorsal Raphe Nuclei , 1978 .
[6] C. de Montigny,et al. Modification of 5‐HT neuron properties by sustained administration of the 5‐HT1A agonist gepirone: Electrophysiological studies in the rat brain , 1987, Synapse.
[7] G. Aghajanian,et al. Electrophysiological and pharmacological characterization of serotonergic dorsal raphe neurons recorded extracellularly and intracellularly in rat brain slices , 1983, Brain Research.
[8] M. Hamon,et al. Presynaptic 5-HT autoreceptors on serotonergic cell bodies and/or dendrites but not terminals are of the 5-HT1A subtype. , 1985, European journal of pharmacology.
[9] S. Haj-Dahmane,et al. K+ channel and 5-hydroxytryptamine1A autoreceptor interactions in the rat dorsal raphe nucleus: Anin vitro electrophysiological study , 1991, Neuroscience.
[10] J. Long,et al. Regional differences in the response of serotonergic neurons in rat CNS to drugs. , 1983, European journal of pharmacology.
[11] S. Hjorth,et al. The 5-HT1A receptor agonist, 8-OH-DPAT, preferentially activates cell body 5-HT autoreceptors in rat brain in vivo , 1988, Naunyn-Schmiedeberg's Archives of Pharmacology.
[12] B. Cox,et al. Pharmacological evidence for the existence of two distinct serotonin receptors in rat brain , 1982, Neuropharmacology.
[13] S. Hjorth,et al. Application of brain microdialysis to study the pharmacology of the 5-HT1A autoreceptor , 1990, Journal of Neuroscience Methods.
[14] S. Hjorth,et al. Effect of the 5-HT1A receptor agonist 8-OH-DPAT on the release of 5-HT in dorsal and median raphe-innervated rat brain regions as measured by in vivo microdialysis. , 1991, Life sciences.
[15] U. Ungerstedt,et al. Influence of a carrier transport process on in vivo release and metabolism of dopamine: dependence on extracellular Na+. , 1989, Life sciences.
[16] F. Artigas,et al. Fluvoxamine preferentially increases extracellular 5-hydroxytryptamine in the raphe nuclei: an in vivo microdialysis study. , 1992, European journal of pharmacology.
[17] P. Kalivas,et al. A Comparison of Axonal and Somatodendritic Dopamine Release Using In Vivo Dialysis , 1991, Journal of neurochemistry.
[18] N. Akaike,et al. Blockade of the voltage-dependent sodium current in isolated rat hippocampal neurons by tetrodotoxin and lidocaine , 1989, Brain Research.
[19] H. Yamamura,et al. Discrimination of Multiple [3H]5‐Hydroxytryptamine Binding Sites by the Neuroleptic Spiperone in Rat Brain , 1981, Journal of neurochemistry.
[20] T. Jessell,et al. Release of dopamine from dendrites in rat substantia nigra , 1976, Nature.
[21] G. Flemström. Intracellular accumulation and permeability effects of some weak acids in the isolated frog gastric mucosa. , 1971, Acta physiologica Scandinavica.
[22] P. Hutson,et al. An in vivo dialysis and behavioural study of the release of 5‐HT by p‐chloroamphetamine in reserpine‐treated rats , 1989, British journal of pharmacology.
[23] U. Ungerstedt. Stereotaxic mapping of the monoamine pathways in the rat brain. , 1971, Acta physiologica Scandinavica. Supplementum.
[24] P. H. Hutson,et al. Hippocampal 5-HT synthesis and release in vivo is decreased by infusion of 8-OHDPAT into the nucleus raphe dorsalis , 1989, Neuroscience Letters.
[25] B. Westerink,et al. Characterization and Pharmacological Responsiveness of Dopamine Release Recorded by Microdialysis in the Substantia Nigra of Conscious Rats , 1991, Journal of neurochemistry.
[26] J. Ieni,et al. The 5-HT1A receptor probe [3H]8-OH-DPAT labels the 5-HT transporter in human platelets. , 1988, Life sciences.
[27] Roberto Invernizzi,et al. Administration of 8‐Hydroxy‐2‐(Di‐n‐Propylamino)tetralin in Raphe Nuclei Dorsalis and Medianus Reduces Serotonin Synthesis in the Rat Brain: Differences in Potency and Regional Sensitivity , 1991, Journal of neurochemistry.
[28] G. Aghajanian,et al. Noradrenergic innervation of serotonergic neurons in the dorsal raphe: Demonstration by electron microscopic autoradiography , 1981, Brain Research.
[29] A. Sleight,et al. In vivo evidence that 5-hydroxytryptamine (5-HT) neuronal firing and release are not necessarily correlated with 5-HT metabolism , 1990, Neuroscience.
[30] P. A. Shore,et al. Reserpine: Basic and Clinical Pharmacology , 1978 .
[31] Y. Okuma,et al. KCl-induced calcium-independent release of endogenous dopamine from rat brain slices , 1986, Brain Research.
[32] J. Palacios,et al. Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I. Serotonin-1 receptors , 1985, Brain Research.
[33] G. Aghajanian,et al. (-)-Propranolol blocks the inhibition of serotonergic dorsal raphe cell firing by 5-HT1A selective agonists. , 1986, European journal of pharmacology.
[34] F. Artigas,et al. Simultaneous Effects of p‐Chloroamphetamine, d‐Fenfluramine, and Reserpine on Free and Stored 5‐Hydroxytryptamine in Brain and Blood , 1992, Journal of neurochemistry.
[35] Roberto Invernizzi,et al. Citalopram's ability to increase the extracellular concentrations of serotonin in the dorsal raphe prevents the drug's effect in the frontal cortex , 1992, Brain Research.
[36] U. Trendelenburg. The TiPS lecture: functional aspects of the neuronal uptake of noradrenaline. , 1991, Trends in pharmacological sciences.
[37] H. Kremer,et al. The hypothalamic lateral tuberal nucleus and the characteristics of neuronal loss in Huntington's disease , 1991, Neuroscience Letters.
[38] F. Hery,et al. The role of serotonin release and autoreceptors in the dorsalis raphe nucleus in the control of serotonin release in the cat caudate nucleus , 1990, Neuroscience.
[39] G. Chiara,et al. Serotonin release estimated by transcortical dialysis in freely-moving rats , 1989, Neuroscience.
[40] F. Hery,et al. Release of Serotonin in Structures Containing Serotoninergic Nerve Cell Bodies: Dorsalis Raphe Nucleus and Nodose Ganglia of the Cat a , 1986, Annals of the New York Academy of Sciences.
[41] D G Grahame-Smith,et al. In Vivo Measurement of Extracellular 5‐Hydroxytryptamine in Hippocampus of the Anaesthetized Rat Using Microdialysis: Changes in Relation to 5‐Hydroxytryptaminergic Neuronal Activity , 1989, Journal of neurochemistry.
[42] Gilles Bonvento,et al. Effect of local injection of 8-OH-DPAT into the dorsal or median raphe nuclei on extracellular levels of serotonin in serotonergic projection areas in the rat brain , 1992, Neuroscience Letters.
[43] C. Sotelo,et al. Direct Immunohistochemical Evidence of the Existence of 5‐HT1A Autoreceptors on Serotoninergic Neurons in the Midbrain Raphe Nuclei , 1990, The European journal of neuroscience.
[44] Lars Olson,et al. Ascending Monoamine Neurons to the Telencephalon and Diencephalon , 1966 .
[45] A. Björklund,et al. Endogenous Release of Neuronal Serotonin and 5‐Hydroxyindoleacetic Acid in the Caudate‐Putamen of the Rat as Revealed by Intracerebral Dialysis Coupled to High‐Performance Liquid Chromatography with Fluorimetric Detection , 1988, Journal of neurochemistry.
[46] J. Pujol,et al. Evidence for the localization of 5HT1A binding sites on serotonin containing neurons in the raphe dorsalis and raphe centralis nuclei of the rat brain , 1985, Neurochemistry International.
[47] M. Raiteri,et al. Carrier-mediated and carrier-independent release of serotonin from isolated central nerve endings , 1982, Neurochemistry International.
[48] J. Glowinski,et al. Release of dopamine in vivo from cat substantia nigra , 1977, Nature.
[49] F. Artaud,et al. Biochemical evidence for the 5-HT agonist properties of PAT (8-hydroxy-2-(di-n-propylamino)tetralin) in the rat brain. , 1984, European journal of pharmacology.
[50] A. Beaudet,et al. The serotonin neurons in nucleus raphe dorsalis of adult rat: A light and electron microscope radioautographic study , 1982, The Journal of comparative neurology.
[51] H. Ralston,et al. Serotonin‐containing structures in the nucleus raphe dorsalis of the cat: An ultrastructural analysis of dendrites, presynaptic dendrites, and axon terminals , 1987, The Journal of comparative neurology.
[52] D G Grahame-Smith,et al. 5‐HT1 agonists reduce 5‐hydroxytryptamine release in rat hippocampus in vivo as determined by brain microdialysis , 1989, British journal of pharmacology.
[53] C. Montigny,et al. Electrophysiologically-identified serotonin receptors in the rat CNS Effect of antidepressant treatment , 1984, Neuropharmacology.
[54] J. Glowinski,et al. Dendritic release of dopamine in the substantia nigra , 1981, Nature.
[55] F. Hery,et al. In vivo release of serotonin in two raphe nuclei (raphe dorsalis and magnus) of the cat , 1982, Brain Research Bulletin.
[56] C. Sinton,et al. Electrophysiological evidence for a functional differentiation between subtypes of the 5-HT1 receptor. , 1988, European journal of pharmacology.
[57] G. Aghajanian,et al. Electrophysiological responses of serotoninergic dorsal raphe neurons to 5‐HT1A and 5‐HT1B agonists , 1987, Synapse.
[58] M. Piercey,et al. Electrophysiological evidence that spiperone is an antagonist of 5-HT1A receptors in the dorsal raphe nucleus. , 1988, European journal of pharmacology.
[59] R. Summers,et al. Antidepressant binding sites in brain: autoradiographic comparison of [3H]paroxetine and [3H]imipramine localization and relationship to serotonin transporter. , 1990, The Journal of pharmacology and experimental therapeutics.
[60] Michael J. Minzenberg,et al. Extracellular serotonin and 5-hydroxyindoleacetic acid in hypothalamus of the unanesthetized rat measured by in vivo dialysis coupled to high-performance liquid chromatography with electrochemical detection: dialysate serotonin reflects neuronal release , 1989, Brain Research.
[61] F Benfenati,et al. Quantitative autoradiographic localization of [3H]imipramine binding sites in the brain of the rat: relationship to ascending 5-hydroxytryptamine neuron systems. , 1983, Proceedings of the National Academy of Sciences of the United States of America.
[62] Autoradiographic localization of [3H]paroxetine specific binding in the rat brain , 1990, Neurochemistry International.
[63] A. Carlsson,et al. Evidence for dopamine release and metabolism beyond the control of nerve impulses and dopamine receptors in rat substantia nigra , 1985, The Journal of pharmacy and pharmacology.
[64] F. Artigas,et al. Regional Distribution of Extracellular 5‐Hydroxytryptamine and 5‐Hydroxyindoleacetic Acid in the Brain of Freely Moving Rats , 1991, Journal of neurochemistry.
[65] C. P. Vandermaelen,et al. Inhibition of serotonergic dorsal raphe neurons by systemic and iontophoretic administration of buspirone, a non-benzodiazepine anxiolytic drug. , 1986, European journal of pharmacology.